![Wan-Jun Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : - $ au 31/05/2026
Wan-Jun Kim is currently Chief Financial Officer & Director at Imbiologics Corp.
since 2024.
Formerly, Mr. Kim was Chief Financial Officer at KoBioLabs, Inc. Education includes undergraduate and graduate degrees from Korea University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMBIOLOGICS CORP. -.--% | 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| IMBIOLOGICS CORP. | Directeur Financier/CFO | 12/11/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| KOBIOLABS, INC | Directeur Financier/CFO | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Korea University
 Korea University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KoBioLabs, Inc.
 KoBioLabs, Inc. BiotechnologyHealth Technology Researches and develops microbiome | Health Technology |
Imbiologics Corp.
 Imbiologics Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops antibodies for autoimmune diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
